What is NDC 55111-293?

55111-293 is the product NDC for Sumatriptan Succinate, Sumatriptan succinate 100 mg/1 tablet, listed with the FDA by Dr. Reddy's Laboratories Limited. It has 7 package NDCs, shown above in 10- and 11-digit form.

Dr. Reddy's Laboratories Limited, NDC labeler code 55111. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Sumatriptan Succinate?

32 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Sumatriptan Succinate NDC 55111-293

NDC codes

FDA NDC Directory

Product NDC (as listed)55111-293Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55111-0293Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
55111-293-01	5511102930155111029301	100 TABLET in 1 BOTTLE (55111-293-01)Marketed from Nov 17, 2009
55111-293-05	5511102930555111029305	500 TABLET in 1 BOTTLE (55111-293-05)Marketed from Nov 17, 2009
55111-293-09	5511102930955111029309	9 BLISTER PACK in 1 CARTON (55111-293-09) / 1 TABLET in 1 BLISTER PACKMarketed from Nov 17, 2009
55111-293-30	5511102933055111029330	30 TABLET in 1 BOTTLE (55111-293-30)Marketed from Nov 17, 2009
55111-293-36	5511102933655111029336	36 TABLET in 1 BOTTLE (55111-293-36)Marketed from Nov 17, 2009
55111-293-90	5511102939055111029390	90 TABLET in 1 BOTTLE (55111-293-90)Marketed from Nov 17, 2009
55111-293-98	5511102939855111029398	3 BLISTER PACK in 1 CARTON (55111-293-98) / 9 TABLET in 1 BLISTER PACKMarketed from Dec 10, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sumatriptan Succinate
Generic name (nonproprietary): sumatriptan succinate
Active ingredients: Sumatriptan succinate — 100 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Dr. Reddy's Laboratories LimitedNDC labeler code 55111
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 076847
Marketing start: Nov 17, 2009
Listing expires: Dec 31, 2027
Other FDA classes: Serotonin 1b Receptor Agonists (Mechanism)Serotonin 1d Receptor Agonists (Mechanism)
Identifiers: Product ID 55111-293_3f0a2fa1-9b69-588d-f3f8-f2af5561edd0SPL ID 3f0a2fa1-9b69-588d-f3f8-f2af5561edd0SPL set ID ac80d018-6abf-2e41-ddea-90b4ff9e9013RxCUI 313160, 313161, 315223UNII J8BDZ68989
Pharmacologic class: Serotonin-1b and Serotonin-1d Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N455111029301 followed by a unit qualifier and the quantity

Package 55111-0293-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 21, 2026.

Indications (excerpt from the label)

Sumatriptan tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use: • Use only if a clear diagnosis of migraine headache has been established. If a patient has no response to the first migraine attack treated with sumatriptan tablets, reconsider the diagnosis of migraine before sumatriptan tablets are administered to treat any subsequent attacks. • Sumatriptan tablets are not indicated for the prevention of migraine attacks. • Safety and effectiveness of sumatriptan tablets have not been established for cluster headache. Sumatriptan is a serotonin (5-HT 1B/1D ) receptor agonist (triptan) indicated for acute treatment of migraine with or w…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 55111-293

What is NDC 55111-293?: 55111-293 is the product NDC for Sumatriptan Succinate, Sumatriptan succinate 100 mg/1 tablet, listed with the FDA by Dr. Reddy's Laboratories Limited. It has 7 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Sumatriptan Succinate.
What is the active ingredient?: Sumatriptan succinate.
Who is the labeler?: Dr. Reddy's Laboratories Limited, NDC labeler code 55111. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Sumatriptan Succinate?: 32 other product NDCs are listed under this name. See all Sumatriptan Succinate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Sumatriptan Succinate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Sumatriptan Succinate	Sumatriptan succinate 4 mg/.5mL	InjectionSubcutaneous	Alembic Pharmaceuticals Limited	46708-656	46708-0656-0146708-0656-05
Sumatriptan Succinate	Sumatriptan succinate 6 mg/.5mL	InjectionSubcutaneous	Alembic Pharmaceuticals Limited	46708-657	46708-0657-0146708-0657-05
Sumatriptan Succinate	Sumatriptan succinate 4 mg/.5mL	InjectionSubcutaneous	Alembic Pharmaceuticals Inc.	62332-656	62332-0656-0162332-0656-05
Sumatriptan Succinate	Sumatriptan succinate 6 mg/.5mL	InjectionSubcutaneous	Alembic Pharmaceuticals Inc.	62332-657	62332-0657-0162332-0657-05
Sumatriptan Succinate	Sumatriptan succinate 6 mg/.5mL	InjectionSubcutaneous	Sun Pharmaceutical Industries, Inc.	47335-276	47335-0276-4047335-0276-41
Sumatriptan Succinate	Sumatriptan succinate 25 mg/1	Tablet, Film coatedOral	Direct_Rx	72189-596	72189-0596-09
Sumatriptan Succinate	Sumatriptan succinate 6 mg/.5mL	InjectionSubcutaneous	NorthStar Rx LLC	72603-141	72603-0141-02
Sumatriptan Succinate	Sumatriptan succinate 6 mg/.5mL	InjectionSubcutaneous	Dr. Reddys Laboratories Inc.,	43598-768	43598-0768-23
Sumatriptan Succinate	Sumatriptan succinate 6 mg/.5mL	InjectionSubcutaneous	Sportpharm LLC	85766-238	85766-0238-02
Sumatriptan Succinate	Sumatriptan succinate 25 mg/1	Tablet, Film coatedOral	Direct_Rx	72189-432	72189-0432-09

All 33 Sumatriptan Succinate NDCs

Other NDCs under ANDA 076847

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 076847
Product	Strength	Form · route	Labeler	Product NDC
Sumatriptan Succinate	Sumatriptan succinate 25 mg/1	TabletOral	Dr. Reddy's Laboratories Limited	55111-291
Sumatriptan Succinate	Sumatriptan succinate 50 mg/1	TabletOral	Dr. Reddy's Laboratories Limited	55111-292
Sumatriptan Succinate	Sumatriptan succinate 50 mg/1	TabletOral	Proficient Rx LP	63187-049
Sumatriptan Succinate	Sumatriptan succinate 100 mg/1	TabletOral	Proficient Rx LP	63187-607
Sumatriptan Succinate	Sumatriptan succinate 25 mg/1	TabletOral	Proficient Rx LP	63187-617
Sumatriptan Succinate	Sumatriptan succinate 100 mg/1	TabletOral	NuCare Pharmaceuticals,Inc.	68071-2283
Sumatriptan Succinate	Sumatriptan succinate 50 mg/1	TabletOral	NuCare Pharmaceuticals,Inc.	68071-4562
Sumatriptan Succinate	Sumatriptan succinate 50 mg/1	TabletOral	Asclemed USA, Inc.	76420-093